Form 4: Alignment Healthcare CFO Robert Thomas Freeman Sells Shares

Robert Thomas Freeman, CFO of Alignment Healthcare, sold shares of common stock over three days in September 2024.

Summary

• Robert Thomas Freeman, the Chief Financial Officer of Alignment Healthcare, Inc., reported the sale of common stock in a Form 4 filing with the SEC.
• The transactions occurred over three days: September 11, 2024, September 12, 2024, and September 13, 2024.
• On September 11, 2024, 8,561 shares were sold at a weighted average price of $10.0091 per share.
• On September 12, 2024, 120,500 shares were sold at a weighted average price of $11.0046 per share.
• On September 13, 2024, 14,500 shares were sold at a weighted average price of $12.0009 per share.
• Following these transactions, Mr. Freeman directly owns 865,407 shares and indirectly owns 264,429 shares through FCO Holdings LLC.
• The sales were executed under a Rule 10b5-1 trading plan adopted on March 15, 2024.

Sentiment

Score: 4

Explanation: The sentiment is slightly negative due to the CFO selling shares, which could indicate a lack of confidence or a need for personal liquidity. However, the existence of a 10b5-1 plan mitigates some of the negative sentiment.

Negatives

• The CFO's sale of shares could be perceived negatively by investors.

Risks

• Continued selling by insiders could put downward pressure on the stock price.

Industry Context

Insider sales are a common occurrence, and investors often look at the context, such as the reason for the sale and the amount of stock sold, to determine the potential impact.

Stakeholder Impact

• Shareholders may react to the news of the CFO selling shares.

Key Dates